Mardi Dier's Net Worth
$16.5 Million
Who is Mardi Dier?
Mardi Dier has an estimated net worth of $16.5 Million. This is based on reported shares across multiple companies, which include ACELYRIN, Inc., Prelude Therapeutics Inc, Ultragenyx Pharmaceutical Inc., Oric Pharmaceuticals, Inc., Adamas Pharmaceuticals Inc, PORTOLA PHARMACEUTICALS INC, and MADRIGAL PHARMACEUTICALS, INC..
SEC CIK
Mardi Dier's CIK is 0001574591
Past Insider Trading and Trends
2015 was Mardi Dier's most active year for acquiring shares with 14 total transactions. Mardi Dier's most active month to acquire stocks was the month of May. 2015 was Mardi Dier's most active year for disposing of shares, totalling 17 transactions. Mardi Dier's most active month to dispose stocks was the month of February. 2017 saw Mardi Dier paying a total of $2,399,721.52 for 250,727 shares, this is the most they've acquired in one year. In 2017 Mardi Dier cashed out on 262,923 shares for a total of $7,395,791.75, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
ACELYRIN, Inc. (SLRN) Snapshot price: $4.25
CFO and CBO
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
∞
| 7.31K |
$18.00 | $131,508.00 | 7.31K |
May 9
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 4
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Prelude Therapeutics Inc (PRLD) Snapshot price: $5.18
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 14
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 16
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 17
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 18
| |||
Form 4
|
∞
| 10K |
$19.00 | $190,000.00 | 10K |
Sep 29
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Sep 24
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Ultragenyx Pharmaceutical Inc. (RARE) Snapshot price: $55.24
CFO & Executive Vice President
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -2.38% | -1.63K |
$40.16 | -$65,420.64 | 66.69K |
Scheduled
|
Oct 14
| ||
Form 4
| -4.85% | -3.48K |
$38.22 | -$133,158.48 | 68.32K |
Oct 12
| |||
Form 4
| +38.60% | 20K |
—
|
—
| 71.81K |
Sep 16
| |||
Form 4
| +33.66% | 13.05K |
$65.71 | -$62,686.08 | 51.81K |
Scheduled
|
Mar 1 - Mar 3
| ||
Form 4
| -14.81% | -6.74K |
$82.00 | -$552,523.59 | 38.76K |
Scheduled
|
Oct 12 - Oct 14
| ||
Form 4
| +13.75% | 5.5K |
—
|
—
| 45.5K |
Mar 1
| |||
Form 4
|
∞
| 40K |
—
|
—
| 40K |
Oct 12
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Oric Pharmaceuticals, Inc. (ORIC) Snapshot price: $9.65
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 12
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 14
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 17
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 16
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 23
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Adamas Pharmaceuticals Inc No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +100.00% | 5K |
—
|
—
| 10K |
Jun 2
| |||
Form 4
|
∞
| 5K |
—
|
—
| 5K |
Jun 3
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 5
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 6
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Oct 10
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||